Connective Tissue Gene Tests (CTGT) has added 12 new assays to its menu of molecular diagnostics for inherited disorders affecting connective tissues.

The Allentown, Pa.-based company is now offering microarray, Sanger sequencing, and next-generation sequencing-based tests for genes associated with Adams-Oliver syndrome, cerebral cavernous malformations, cutis laxa, multiple self-healing squamous epithelioma, opsismodysplasia, and supervalvular aortic stenosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.